Table 2.
Demographic and clinical characteristics of rheumatoid arthritis (RA) and control cohorts*
| Patients with RA (N=582) | Subjects without RA (N=603) | p value | |
|---|---|---|---|
| Age at RA diagnosis/index date, mean ± SD in years | 57.7 ± 15.1 | 58.2 ± 15.2 | 0.58 |
| Years of follow up, mean ± SD | 16.4 ± 10.5 | 19.3 ± 11.1 | -- |
| Female, N (%) | 427 (73.4%) | 441 (73.1%) | 0.93 |
| Smoking status at baseline, N (%) | |||
| Current smoker | 164 (28.2%) | 144 (23.9%) | <0.01 |
| Former smoker | 144 (24.7%) | 118 (19.6%) | |
| Chest X-ray documented, N (%) | 230 (39.5%) | 352 (58.4%) | <0.01 |
| Fibrotic changes on chest X-ray, N (%) | 157 (27.0%) | 154 (25.5%) | 0.57 |
| PFT documented, N (%) | 111 (19.1%) | 104 (17.2%) | 0.42 |
| PFT restrictive pattern (TLC ≤ 80% predicted), N (%) | 27 (4.6%) | 11 (1.8%) | <0.01 |
| CT documented, N (%) | 78 (13.4%) | 85 (14.1%) | 0.73 |
| CT reported presence of parenchymal disease, N (%) | 38 (6.5%) | 24 (4.0%) | 0.05 |
Except where indicated otherwise, values are the number (%) of patients.
RA = rheumatoid arthritis; SD = standard deviation; PFT = pulmonary function test; TLC = total lung capacity; CT = computed tomography